You're reading the free version. Trader adds the live tape and alerts.
Start tracking
LGND Exercise Disclosure
Haas Jason · SEC Form 4 · Filed Jun 15, 2026
Exercise
Calculated transaction value
$0
Haas Jason Director
LGND
Transaction date
Jun 12, 2026
Public filing date
Jun 15, 2026
Filing lag
Filed 3 days later
LGND daily price context
Close on/before transaction
$255.54
Jun 12, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Non-Qualified Stock Option (right to buy) on Common Stock
- Quantity / price
- 3,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0002001011-26-000104
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$1.86M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Ligand Pharmaceuticals Inc LGND | Exercise | Jun 12, 2026 | $154.68K |
| Ligand Pharmaceuticals Inc LGND | Exercise | Jun 12, 2026 | $51.56K |
| Ligand Pharmaceuticals Inc LGND | Sale | Jun 12, 2026 | $765.03K |
| Ligand Pharmaceuticals Inc LGND | Sale | Jun 12, 2026 | $886.29K |
| Ligand Pharmaceuticals Inc LGND Current | Exercise | Jun 12, 2026 | $0 |
| Ligand Pharmaceuticals Inc LGND | Exercise | Jun 12, 2026 | $0 |